Accolade Net Worth

Accolade Net Worth Breakdown

  ACCD
The net worth of Accolade is the difference between its total assets and liabilities. Accolade's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Accolade's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Accolade's net worth can be used as a measure of its financial health and stability which can help investors to decide if Accolade is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Accolade stock.

Accolade Net Worth Analysis

Accolade's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Accolade's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Accolade's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Accolade's net worth analysis. One common approach is to calculate Accolade's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Accolade's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Accolade's net worth. This approach calculates the present value of Accolade's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Accolade's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Accolade's net worth. This involves comparing Accolade's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Accolade's net worth relative to its peers.

Enterprise Value

422.68 Million

To determine if Accolade is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Accolade's net worth research are outlined below:
Accolade generated a negative expected return over the last 90 days
Accolade has high historical volatility and very poor performance
Accolade has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 165.26 M.
Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Accolade has a poor financial position based on the latest SEC disclosures
Over 82.0% of the company shares are held by institutions such as insurance companies
Latest headline from investing.com: Disposition of 510 shares by Robert Cavanaugh of Accolade subject to Rule 16b-3

Accolade Quarterly Good Will

278.19 Million

Accolade uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Accolade. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Accolade's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of April 2024
Upcoming Quarterly Report
View
4th of July 2024
Next Financial Report
View
29th of February 2024
Next Fiscal Quarter End
View
25th of April 2024
Next Fiscal Year End
View
30th of November 2023
Last Quarter Report
View
28th of February 2023
Last Financial Announcement
View

Accolade Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Accolade target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Accolade's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   15  Strong Buy
Most Accolade analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Accolade stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Accolade, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Accolade Target Price Projection

Accolade's current and average target prices are 3.36 and 14.77, respectively. The current price of Accolade is the price at which Accolade is currently trading. On the other hand, Accolade's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Accolade Market Quote on 23rd of October 2024

Low Price3.25Odds
High Price3.39Odds

3.36

Target Price

Analyst Consensus On Accolade Target Price

Low Estimate13.44Odds
High Estimate16.39Odds

14.77

Historical Lowest Forecast  13.44 Target Price  14.77 Highest Forecast  16.39
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Accolade and the information provided on this page.

Know Accolade's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Accolade is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accolade backward and forwards among themselves. Accolade's institutional investor refers to the entity that pools money to purchase Accolade's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-06-30
1.7 M
Dimensional Fund Advisors, Inc.2024-06-30
1.7 M
Prosight Management, Lp2024-06-30
1.5 M
Fairman Group Llc2024-06-30
1.1 M
Jane Street Group Llc2024-06-30
M
Jfg Wealth Management, Llc2024-06-30
854.2 K
Bellevue Group Ag2024-06-30
842.6 K
Clearline Capital Lp2024-06-30
830.8 K
Goldman Sachs Group Inc2024-06-30
776.8 K
Blackrock Inc2024-06-30
6.2 M
Ark Investment Management Llc2024-06-30
5.6 M
Note, although Accolade's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Accolade's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 270.6 M.

Market Cap

474.85 Million

Project Accolade's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.29)(0.30)
Return On Capital Employed(0.17)(0.18)
Return On Assets(0.13)(0.13)
Return On Equity(0.22)(0.21)
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.24) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.24.
When accessing Accolade's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Accolade's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Accolade's profitability and make more informed investment decisions.
Please note, the presentation of Accolade's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accolade's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Accolade's management manipulating its earnings.

Evaluate Accolade's management efficiency

Accolade has return on total asset (ROA) of (0.0727) % which means that it has lost $0.0727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1861) %, meaning that it created substantial loss on money invested by shareholders. Accolade's management efficiency ratios could be used to measure how well Accolade manages its routine affairs as well as how well it operates its assets and liabilities. As of October 23, 2024, Return On Tangible Assets is expected to decline to -0.3. In addition to that, Return On Capital Employed is expected to decline to -0.18. At present, Accolade's Asset Turnover is projected to slightly decrease based on the last few years of reporting.
Last ReportedProjected for Next Year
Book Value Per Share 5.95  3.07 
Tangible Book Value Per Share 0.02  0.02 
Enterprise Value Over EBITDA(13.08)(13.73)
Price Book Value Ratio 1.72  1.81 
Enterprise Value Multiple(13.08)(13.73)
Price Fair Value 1.72  1.81 
Enterprise Value823.7 M422.7 M
Accolade showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue
0.6273
Revenue
441 M
Quarterly Revenue Growth
0.098
Revenue Per Share
5.706
Return On Equity
(0.19)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Accolade insiders, such as employees or executives, is commonly permitted as long as it does not rely on Accolade's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Accolade insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Accolade Corporate Filings

F4
18th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
8th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
7th of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
21st of June 2024
Other Reports
ViewVerify
Accolade time-series forecasting models is one of many Accolade's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Accolade's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Accolade Earnings per Share Projection vs Actual

Accolade Corporate Management

Robert CavanaughPresidentProfile
Michael HiltonChief OfficerProfile
James MDSenior OfficerProfile
Colin McHughChief OfficerProfile
Jennifer HansonExecutive OfficerProfile
Kristen WeeksCorp StrategyProfile
MD MBAChief DeliveryProfile

Already Invested in Accolade?

The danger of trading Accolade is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Accolade is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Accolade. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Accolade is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.02)
Revenue Per Share
5.706
Quarterly Revenue Growth
0.098
Return On Assets
(0.07)
Return On Equity
(0.19)
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.